Companies · Biotech / Pharma

IdentifySensors Biologics Corp.

SHAKER HEIGHTS · Biotech / Pharma · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on IdentifySensors Biologics Corp. — recommendation, valuation, rhythm, risks.
$2.1M
Total raised · real
2
Rounds
1.5×
Latest step-up
Top 64%
Sector rank · raised
Seed
Latest stage · inferred · Sat Dec 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

IdentifySensors Biologics Corp. looks under-valued against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech/pharma sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.46× the median modeled value of Seed Biotech / Pharma companies in 2022–2024 (14 peers) — value vs value, same stage and era.
Quiet
  • Last raise 2.5 yr ago; this sector typically re-raises about every 15 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotech / Pharma

IdentifySensors Biologics Corp. is one of 227 Biotech / Pharma companies tracked from SHAKER HEIGHTS. By capital raised it ranks in the long tail (ahead of 37% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2020
Year incorporated
2023-12-23
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2021-03-09 Raised $809K (real) Modeled valuation $27M (est)$809K$27MPre-Seed2021Seed · 2023-12-23 Raised $1.3M (real) Modeled valuation $8.0M (est)$1.3M$8.0MSeed2023+$1.3MCumulative $2.1M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$809K · 2021
Seed$1.3M · 2023

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$8.0M
Base estimate est.
$923K
Conservative case
$24.4M
Upside case
$6.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech/pharma sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $27.4M · 2021-03-092021Seed · modeled $8.0M · 2023-12-232023
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
33%
Survival probability
15% low · 51% high
1.71×/yr
Annual markup
2.24×/yr upside case
2.5 yr
Elapsed time used
2.5 yr actual, capped for stale marks
biotech/pharma
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
33 mo
Avg between rounds
$738K/yr
Capital velocity
5.3 yr
On record since
2021
First round
2
Rounds on file
How it compares to the market

Benchmarked against 227 companies in Biotech / Pharma. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.4× of median
This company$2.1M
Sector median$5.6M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.7× of median
This company$1.3M
Sector median$1.9M
Modeled value — vs sector median (estimate, all stages) 0.3× of median
This company$8.0M
Sector median$30.5M

Raised more than 37% of sector peers (real $). Modeled value above 31% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #11 of 14.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0MCapital raised (log)Outer Biosciences, LLC · Seed Raised $4.0M · modeled $66.1M (est)Slate Bio, Inc. · Seed Raised $4.8M · modeled $29.9M (est)CASS Pharmaceuticals, Inc. · Seed Raised $2.1M · modeled $26.0M (est)FOOP Organic Biosciences, Inc. · Seed Raised $2.0M · modeled $25.8M (est)Trio Pharmaceuticals, Inc. · Seed Raised $1.9M · modeled $22.5M (est)Aruka Bio, Inc. · Seed Raised $3.5M · modeled $19.0M (est)Yatiri Bio, Inc. · Seed Raised $2.9M · modeled $18.1M (est)Galatea Bio, Inc. · Seed Raised $3.7M · modeled $16.2M (est)Sedare Biosciences, Inc. · Seed Raised $2.5M · modeled $15.5M (est)Klothea Bio, Inc. · Seed Raised $2.9M · modeled $12.1M (est)Cornovus Pharmaceuticals Inc. · Seed Raised $3.1M · modeled $3.0M (est)IdentifySensors Biologics Corp. (this company) Raised $2.1M · modeled $8.0M (est)IdentifySensors Biologics Corp.
CompanyStageRaised · realValue · estvs peer med.
Outer Biosciences, LLCSeed$4.0M$66.1M3.85×
Slate Bio, Inc.Seed$4.8M$29.9M1.74×
CASS Pharmaceuticals, Inc.Seed$2.1M$26.0M1.51×
FOOP Organic Biosciences, Inc.Seed$2.0M$25.8M1.50×
Trio Pharmaceuticals, Inc.Seed$1.9M$22.5M1.31×
Aruka Bio, Inc.Seed$3.5M$19.0M1.11×
Yatiri Bio, Inc.Seed$2.9M$18.1M1.05×
Galatea Bio, Inc.Seed$3.7M$16.2M0.95×
Sedare Biosciences, Inc.Seed$2.5M$15.5M0.90×
Klothea Bio, Inc.Seed$2.9M$12.1M0.71×
IdentifySensors Biologics Corp. this companySeed$2.1M$8.0M0.46×
Cornovus Pharmaceuticals Inc.Seed$3.1M$3.0M0.18×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$809K2021-03-09$4.5M$27.4M90%
Seed$1.3M2023-12-23$6.3M$8.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$809K2021-03-09
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Seed$1.3M2023-12-23
    • Raised again after 33 mo — slower than the ~15 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 3 investors on this round.
Intelligence
2026 ~Q4
Modeled next raise · ~33mo cadence
$1.9M
Modeled next size est.range $1.3M$3.1M
1.5×
Last step-up
$738K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Bruce Raben2 other2021-03
Gregory Hummer1 other2021-03
Ann Hawkins2021-03
Registry & provenance

IdentifySensors Biologics Corp. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1817371
SEC CIK
2020
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
FOOP Organic Biosciences, Inc.Biotech / PharmaSeed$2.0M$25.8Msame sector · same stage
Light Bio, Inc.Biotech / PharmaSeed$2.0M$82.3Msame sector · same stage
CASS Pharmaceuticals, Inc.Biotech / PharmaSeed$2.1M$26.0Msame sector · same stage
Rapid Therapeutic Science Laboratories, Inc.Biotech / PharmaSeed$2.1M$15.2Msame sector · same stage
Trio Pharmaceuticals, Inc.Biotech / PharmaSeed$1.9M$22.5Msame sector · same stage
Base Pair Biotechnologies, Inc.Biotech / PharmaSeed$1.9M$76.6Msame sector · same stage
Animal Biosciences, Inc.Biotech / PharmaSeed$2.3M$31.6Msame sector · same stage
3Bar Biologics, Inc.Biotech / PharmaSeed$2.4M$26.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Applied Biosensors, Inc.\DEOther TechnologyPre-Seed$5.7M83%
IdentifySensors Fresh Food Enterprises, LLCAgtech / FoodtechPre-Seed$6.5M83%
ImmuneSensor Therapeutics, Inc.BiotechnologySeries A$114.6M82%
Clinical Sensors, Inc.BiotechnologyPre-Seed$11.0M82%
Reveal Biosensors, Inc.BiotechnologyPre-Seed$12.4M81%
Smart Health Diagnostics CoBiotechnologySeries B$1.8M80%
Key Biologics Holdings, LLCBiotech / PharmaSeries A$167.5M80%
Intelligent Bio Solutions Inc.Biotech / PharmaSeries A$25.8M79%
Frequently asked
How much funding has IdentifySensors Biologics Corp. raised?
IdentifySensors Biologics Corp. has raised approximately $2.1M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is IdentifySensors Biologics Corp.'s estimated valuation?
Provath's modeled valuation for IdentifySensors Biologics Corp. is approximately $8.0M (modeled range $923K–$24.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is IdentifySensors Biologics Corp. at?
IdentifySensors Biologics Corp.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Sat Dec 23.
What does IdentifySensors Biologics Corp. do and where is it based?
IdentifySensors Biologics Corp. operates in the Biotech / Pharma sector, based in SHAKER HEIGHTS.
Explore related

See where IdentifySensors Biologics Corp. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at IdentifySensors Biologics Corp., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.